Cost-Effectiveness of Statins in Older Adults: Further Evidence That Less Is More

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 21 Apr 2015 English Publisher:American College of PhysiciansJournal:Annals of Internal Medicine, volume 162, pages 590-591 (issn: 0003-4819, eissn: 1539-3704,

Copyright policy )

Authors: Michael W, Rich;

doi: 10.7326/m15-0535

pmid: 25894030

Cost-Effectiveness of Statins in Older Adults: Further Evidence That Less Is More

- Summary
- Subjects
- Metrics

Abstract

In this issue, Odden and colleagues evaluated the population benefit and cost-effectiveness of statins in older U.S. adults without a history of cardiovascular disease. The editorialist acknowledge...

Related Organizations

University of Mary
United States
Washington University in St. Louis
United States

Keywords

Primary Prevention, Cardiovascular Diseases, Risk Factors, Cost-Benefit Analysis, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cognition Disorders, Aged

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	4
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%